Advances in B Cell Biology: RA, SLE,
and Vasculitis

Advances in B Cell Therapy for RA

Release Date:   November 10, 2011
Expiration Date:   November 10, 2012

	How to Obtain AMA PRA Category 1 Credit™ Watch the Webcast. Complete the CME posttest (each question must be answered correctly). Login to your myCME account. Complete the credit and evaluation form. Print your personalized CME certificate. Technical Requirements

Estimated Time of Completion:  30 minutes

Description

Advances in B Cell Biology: RA, SLE, and Vasculitis is a series of CME-accredited webcasts in which expert faculty bridge the gap between the complexities of current immunologic data and how they can be incorporated into clinical practice. The series is designed for busy clinicians interested in keeping abreast of cutting-edge data and novel therapies in treatment of ARDs – information that can have significant positive impacts on patient outcomes.

Learning Objectives

1. Discuss the most recently presented clinical data at EULAR relating to the usage of B cell-directed therapies.
2. Examine issues related to efficacy and safety with novel agents and/or administration.
3. Review data using combined biologic agents including B cell-targeting as well as in specific situations in RA.

Target Audience

This activity is directed to rheumatologists, immunologists, allied health professionals, and other medical professionals who manage patients with rheumatic diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of  0.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Activity Directors

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, Ohio

Gregg J. Silverman, MD
Co-Director, Musculoskeletal Center of Excellence
Professor of Medicine and Pathology
NYU School of Medicine
New York, New York

Faculty

William Rigby, MD
Professor of Medicine
Vice-Chair, Medicine
Dartmouth Medical School
Lebanon, New Hampshire

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), the Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:

All other planners, CME staff, and content reviewers have no relevant financial relationships to disclose.

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:
Genentech & Biogen Idec
Human Genome Sciences, Inc.

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education and
the R.J. Fasenmyer Center for Clinical Immunology.

CME Disclaimer